AN OPEN-LABEL, MULTI-SITE PHASE 2 STUDY OF THE SAFETY AND FEASIBILITY OF MDMA-ASSISTED PSYCHOTHERAPY FOR EATING DISORDERS

Registry ID

MED1

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

MULTIDISIPLINARY ASSOCIATION FOR PSYCHEDELIC STUDIES

Completion date

2023-04-12

Last update

2020-10-30

Conditions

• BINGE EATING DISORDER
• ANOREXIA

Related clinical trials

• FECAL MICROBIOTA TRANSPLANTATION (FMT) TO NORMALIZE GUT MICROBIOTA, METABOLOMICS, IMMUNOLOGY, COGNITIVE AND AFFECTIVE PROCESSING IN PATIENTS SUFFERING FROM ANOREXIA NERVOSA
• EFFECTS OF ANOREXIA ON PEAK BONE MASS
• A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL STUDY TO EVALUATE THE MAINTENANCE OF EFFICACY OF SPD489 IN ADULTS AGED 18-55 YEARS WITH MODERATE TO SEVERE BINGE EATING DISORDER

View on source registry